Category: Zacks Small Cap Research

1525354555671540 / 708 POSTS
OTC:GTBPLast summer the immuno-oncology world was elated with the FDA’s approval of the most exciting cancer therapy in years: Novartis’ (NVS) chimeric antigen receptor T-cell (CAR-T) therapy, Kymriah. The cell-based approach received approval for re ...
By John Vandermosten, CFANASDAQ:AZRXAzurRx BioPharma, Inc. (NASDAQ:AZRX) announced the completion of the Phase IIa MS1819-SD trial on June 29, 2018 and expects to provide a formal report presenting the data in the fall of 2018 at an as yet unidentifi ...
By Brian Marckx, CFANASDAQ:VIVEREAD THE FULL VIVE RESEARCH REPORTLast week Viveve (NASDAQ:VIVE) announced what we would characterize as potentially compelling 6-month data from its ongoing SUI 12-month feasibility study. As a refresher, this is the s ...
By John Vandermosten, CFATSE:PMN.TOOTC:ARFXFREAD THE FULL PMN.TO RESEARCH REPORTInitiating CoverageWe are initiating coverage of ProMIS Neurosciences Inc. (TSE:PMN.TO) (OTC:ARFXF) with a CAD$7.00 price target based on our forecast for product sales a ...
NASDAQ:CKPT | NYSE:MRK | OTC:RHHBYIt was only eight years ago, at the June 2010 American Society of Clinical Oncology conference, when Bristol Myers presented groundbreaking data showing a significant survival advantage in melanoma for ipilimumab, th ...
CSE:MPLS.CNFSE:48GGoverMedia Plus Canada Corp. (CSE:MPLS.CN) (FSE:48G) is a Canadian company with a Russian internet technology subsidiary. It operates in various fields including e-commerce, social media, cryptocurrencies, ICOs and blockchain. Gover ...
By David Bautz, PhDNASDAQ:MTFBREAD THE FULL RESEARCH REPORTBusiness UpdateMotif Bio Plc (NASDAQ:MTFB) is a biopharmaceutical company focused on the development of antibiotic compounds for difficult to treat bacterial infections. The company’s lead as ...
By David Bautz, PhDNASDAQ:CFRXREAD THE FULL RESEARCH REPORTBusiness UpdatePresentations at ASM 2018 Highlight New Gram-Negative Lysin Program and CF-301 In June 2018, ContraFect Corp. (NASDAQ:CFRX) had multiple presentations at the American Society f ...
By M. MarinNASDAQ:FUVREAD THE FULL RESEARCH REPORTOregon-based Arcimoto (NASDAQ:FUV) is positioning itself to benefit from transitions in mobility as governments mandate lower car emissions, consumers are increase adopting green automotive solutions ...
By David Bautz, PhDNASDAQ:VKTXREAD THE FULL RESEARCH REPORTFinancial UpdateOn June 12, 2018, Viking Therapeutics, Inc. (NASDAQ:VKTX) announced the closing of a public offering of 8.625 million shares at $9.00 per share, which included 1.125 million s ...
1525354555671540 / 708 POSTS